Evidence map›Paper›PMID 41760144›Full record

ArticleBMJ open2026

Promoting engagement in patient-initiated follow-up and self-care behaviours: acceptability of the 'ACT now & check-it-out' intervention for head and neck cancer (PETNECK2 study).

Lauren Matheson, Eila Watson, Tessa Fulton-Lieuw, Saloni Mittal, Piers Gaunt, Julia Sissons, Evaggelia Liaskou, Claire Gaunt, Paul Nankivell, Hisham Mehanna and 2 more

Abstract readMulticenter Study
In one paragraph

Article in BMJ open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Lauren MathesonOxford School of Nursing and Midwifery, Oxford Brookes University, Oxford, UK l.matheson@brookes.ac.uk.ORCID http://orcid.org/0000-0003-2828-7528
Eila WatsonOxford School of Nursing and Midwifery, Oxford Brookes University, Oxford, UK.ORCID http://orcid.org/0000-0002-3592-1315
Tessa Fulton-LieuwDepartment of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.ORCID http://orcid.org/0000-0002-9857-1834
Saloni MittalDepartment of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.ORCID http://orcid.org/0009-0008-9315-0361
Piers GauntCancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK.ORCID http://orcid.org/0000-0001-8665-300X
Julia SissonsCancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK.
Evaggelia LiaskouCancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK.
Claire GauntCancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK.ORCID http://orcid.org/0009-0002-6000-9093
Paul NankivellDepartment of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.ORCID http://orcid.org/0000-0003-4664-6117
Hisham MehannaDepartment of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.ORCID http://orcid.org/0000-0002-5544-6224
Jo BrettOxford School of Nursing and Midwifery, Oxford Brookes University, Oxford, UK.ORCID http://orcid.org/0000-0002-5116-4238
PETNECK2 Research Team

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesDue to increasing incidence of head and neck cancer (HNC) and overwhelming clinical demand on follow-up services, a new risk-stratified pathway, patient-initiated follow-up (PIFU) with a patient support package is being evaluated (PETNECK2 study). We aimed to (a) explore acceptability to both HNC patients and health professionals and the impact on self-management behaviours including self-surveillance and fear of cancer recurrence and (b) conduct intervention optimisation.

designQualitative interviews conducted 1-2 months after receiving the PIFU support package.

settingEight hospital trusts across the UK.

participants25 patients around 1-year post-HNC treatment receiving the PETNECK2 intervention, and 7 health professionals from NHS Trusts involved in recruitment and/or intervention delivery.

interventionAll patients received the intervention (PIFU) following a clear PET-CT scan, which included a face-to-face education session with a health professional and a digital app and/or booklet, that aimed to support engagement in PIFU self-care behaviours (including regularly checking for symptom changes; prompt help-seeking; self-management of fear of recurrence). Patients had open access to their hospital team if concerns arose.

resultsThe PIFU intervention with a patient support package was largely acceptable to health professionals and most patients. Engagement in new habitual self-care behaviours was evident in most, influenced by having increased knowledge and confidence regarding these behaviours, provided by key elements of the PIFU support package (eg, demonstration of self-examination). Acceptability appeared lower in a few patients reporting low self-efficacy for self-examination, ongoing challenges with fear of recurrence and concerns over no scheduled appointments.

conclusionsOur intervention support package was largely acceptable and promoted patient engagement with PIFU and key self-management behaviours. Findings can usefully inform the design of future PIFU support packages and highlight important considerations for future evaluations of patient acceptability of PIFU pathways. Following intervention optimisation, a UK-wide trial is now underway. TRIAL REGISTRATION NUMBER: ISRCTN13709798.

Indexed as

Head and Neck NeoplasmsPatient Acceptance of Health CarePatient ParticipationSelf CareAdherence InterventionsAdultAgedFearFemaleHumansMaleMiddle AgedNeoplasm Recurrence, LocalPatient Education as TopicQualitative ResearchUnited KingdomBehaviorHead & neck tumoursPatient-Centered CarePsychosocial InterventionSelf-Management

Identifiers

PMID41760144
PMCPMC12959068

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.